BIS icon

ProShares UltraShort NASDAQ Biotechnology
BIS

Overview Fund Activity

7 hedge funds and large institutions have $4.82M invested in ProShares UltraShort NASDAQ Biotechnology in 2014 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
7
Holders Change
+5
Holders Change %
+250%
% of All Funds
0.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
1
Reduced
–
Closed
1
Calls
$1.38M
Puts
$2.79M
Net Calls
-$1.41M
Net Calls Change
-$1.41M

Top Buyers

1
HVC
Healthcare Value Capital
New Jersey
+$2.23M
2
CANY
Caxton Associates (New York)
New York
+$891K
3
BGA
Belmont Global Advisors
Texas
+$891K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$471K
5
SM
Southport Management
Wyoming
+$267K

Top Sellers

1
TRCT
Tower Research Capital (TRC)
New York
-$43K
Name Holding Trade Value Shares
Change 		Shares
Change %
HVC
1
Healthcare Value Capital
New Jersey
$2.23M +$2.23M +6,250 New
CANY
2
Caxton Associates (New York)
New York
$891K +$891K +2,500 New
BGA
3
Belmont Global Advisors
Texas
$891K +$891K +2,500 New
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$471K +$471K +1,320 New
SM
5
Southport Management
Wyoming
$267K +$267K +750 New
Bank of America
6
Bank of America
North Carolina
$36K +$36K +100 New
U
7
UBS
Switzerland
$32K +$31.6K +88 +8,800%
TRCT
8
Tower Research Capital (TRC)
New York
– -$43K -104 Closed